Oxygen pressurized X-ray crystallography: Probing the dioxygen binding site in cofactorless urate oxidase and implications for its catalytic mechanism

Biophysical Journal

Volumn 95, Issue 5, 2008, Pages 2415-2422

  Colloc'h, Nathalie ^a   Gabison, Laure ^b   Monard, Gérald ^c   Altarsha, Muhannad ^c,d   Chiadmi, Mohamed ^b   Marassio, Guillaume ^a   Sopkova De Oliveira Santos, Jana ^e   El Hajji, Mohamed ^f   Castro, Bertrand ^f   Abraini, Jacques H ^a   Prangé, Thierry ^b  

^a GIP CYCERON   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c NANCY UNIVERSITÉ   (France)

^d MAX PLANCK INSTITUT FÜR KOHLENFORSCHUNG   (Germany)

^e UNIVERSITÉ DE CAEN   (France)

^f SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN; SODIUM CHLORIDE; URATE OXIDASE; WATER; XENON;

ARTICLE; ASPERGILLUS FLAVUS; BINDING SITE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; CRYSTALLIZATION; ENZYMOLOGY; METABOLISM; METHODOLOGY; PRESSURE; X RAY CRYSTALLOGRAPHY;

ASPERGILLUS FLAVUS; BINDING SITES; CATALYSIS; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; MODELS, MOLECULAR; OXYGEN; PRESSURE; SODIUM CHLORIDE; URATE OXIDASE; WATER; XENON;

EID: 48349141173     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1529/biophysj.107.122184     Document Type: Article

References (55)

1. 13C-NMR evidence. Tetrahedron Lett. 32:7477-7480.
2. 13C-NMR/isotope-labelling evidence. Tetrahedron Lett. 33:6691-6694.
3. Kahn, K., P. Serfozo, and P. A. Tipton. 1997. Identification of the true product of the urate oxidase reaction. J. Am. Chem. Soc. 119:5435-5442.
4. Sarma, A. D., P. Serfozo, K. Kahn, and P. A. Tipton. 1999. Identification and purification of hydroxyisourate hydrolase, a novel ureide-metabolizing enzyme. J. Biol. Chem. 274:33863-33865.
5. Lee, Y., D. H. Lee, C. W. Kho, A. Y. Lee, M. Jang, S. Cho, C. H. Lee, J. S. Lee, P. K. Myung, B. C. Park, and S. G. Park. 2005. Transthyretin-related proteins function to facilitate the hydrolysis of 5-hydroxyisourate, the end product of the uricase reaction. FEBS Lett. 579:4769-4774.
6. Lee, Y., B. C. Park, H. Lee do, K. H. Bae, S. Cho, C. H. Lee, J. S. Lee, P. K. Myung, and S. G. Park. 2006. Mouse transthyretin-related protein is a hydrolase which degrades 5-hydroxyisourate, the end product of the uricase reaction. Mol. Cells. 22:141-145.
7. Ames, B. N., R. Cathcart, E. Schwiers, and P. Hochstein. 1981. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc. Natl. Acad. Sci. USA. 78:6858-6862.
8. Wu, X. W., D. M. Muzny, C. C. Lee, and C. T. Caskey. 1992. Two independent mutational events in the loss of urate oxidase during hominoid evolution. J. Mol. Evol. 34:78-84.
9. Legoux, R., B. Delpech, X. Dumont, J. C. Guillemot, P. Ramond, D. Shire, D. Caput, P. Ferrara, and G. Loison. 1992. Cloning and expression in Escherichia coli of the gene encoding Aspergillus flavus urate oxidase. J. Biol. Chem. 267:8565-8570.
10. Bayol, A., J. Capdevielle, P. Malazzi, A. Buzy, M. C. Bonnet, N. Colloc'h, J. P. Mornon, D. Loyaux, and P. Ferrara. 2002. Modification of a reactive cysteine explains differences between rasburicase and Uricozyme, a natural Aspergillus flavus uricase. Biotechnol. Appl. Biochem. 36:21-31.
11. Colloc'h, N., M. El Hajji, B. Bachet, G. L'Hermite, M. Schiltz, T. Prangé, B. Castro, and J. P. Mornon. 1997. Crystal structure of the protein drug urate oxidase-inhibitor complex at 2.05 Å resolution. Nat. Struct. Biol. 4:947-952.
12. Retailleau, P., N. Colloc'h, D. Vivarès, F. Bonneté, B. Castro, M. El Hajji, J. P. Mornon, G. Monard, and T. Prangé. 2004. Complexed and ligand-free high-resolution structures of urate oxidase (Uox) from Aspergillus flavus: a reassignment of the active-site binding mode. Acta Crystallogr. D60:453-462.
13. Retailleau, P., N. Colloc'h, D. Vivarès, F. Bonneté, B. Castro, M. El Hajji, and T. Prangé. 2005. Urate oxidase from Aspergillus flavus: new crystal-packing contacts in relation to the content of the active site. Acta Crystallogr. D61:218-229.
14. Gabison, L., M. Chiadmi, N. Colloc'h, B. Castro, M. El Hajji, and T. Prangé. 2006. Recapture of [S]-allantoin, the product of the two-step degradation of uric acid, by urate oxidase. FEBS Lett. 580:2087-2091.
15. Prangé, T., M. Schiltz, L. Pernot, N. Colloc'h, S. Longhi, W. Bourguet, and R. Fourme. 1998. Exploring hydrophobic sites in proteins with xenon or krypton. Proteins. 30:61-73.
16. Colloc'h, N., J. Sopkova-de Oliveira Santos, P. Retailleau, D. Vivarès, F. Bonneté, B. Langlois d'Estaintot, B. Gallois, A. Brisson, J. J. Risso, M. Lemaire, T. Prangé, and J. H. Abraini. 2007. Protein crystallography under xenon and nitrous oxide pressure: comparison with in vivo pharmacology studies and implications for the mechanism of inhaled anesthetic action. Biophys. J. 92:217-224.
17. Duff, A. P., D. M. Trambaiolo, A. E. Cohen, P. J. Ellis, G. A. Juda, E. M. Shepard, D. B. Langley, D. M. Dooley, H. C. Freeman, and J. M. Guss. 2004. Using xenon as a probe for dioxygen-binding sites in copper amine oxidases. J. Mol. Biol. 344:599-607.
18. Hiromoto, T., S. Fujiwara, K. Hosokawa, and H. Yamaguchi. 2006. Crystal structure of 3-hydroxybenzoate hydroxylase from Comamonas testosteroni has a large tunnel for substrate and oxygen access to the active site. J. Mol. Biol. 364:878-896.
19. Roeser, D., B. Schmidt, A. Preusser-Kunze, and M. G. Rudolph. 2007. Probing the oxygen-binding site of the human formylglycine-generating enzyme using halide ions. Acta Crystallogr. D63:621-627.
20. Bonneté, F., D. Vivarès, C. Robert, and N. Colloc'h. 2001. Interactions in solution and crystallization of Aspergillus flavus urate oxidase. J. Cryst. Growth. 232:330-339.
21. Schiltz, M., T. Prangé, and R. Fourme. 1994. On the preparation and x-ray data collection of isomorphous xenon derivatives. J. Appl. Cryst. 27:950-960.
22. Schiltz, M., R. Fourme, and T. Prangé. 2003. Use of noble gases xenon and krypton as heavy atoms in protein structure determination. Methods Enzymol. 374:83-119.
23. Otwinowski, Z., and W. Minor. 1997. Processing of x-ray diffraction data collected in the oscillation mode. Methods Enzymol. 276:307-326.
24. Collaborative Computational Project Number 4. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D50:760-763.
25. Murshudov, G. N., A. A. Vagin, and E. J. Dodson. 1997. Refinement of macromolecular structures by the Maximum-Likelihood method. Acta Crystallogr. D53:240-255.
26. Leslie, A. G. 2006. The integration of macromolecular diffraction data. Acta Crystallogr. D62:48-57.
27. Sheldrick, G. M., and T. R. Schneider. 1997. SHELXL: High-resolution refinement. Methods Enzymol. 227:319-343.
28. Jones, T. A., J. Y. Zou, S. W. Cowan, and M. Kjeldgaard. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A. 47:110-119.
29. Miller, K. W. 2002. The nature of sites of general anaesthetic action. Br. J. Anaesth. 89:17-31.
30. Tilton, R. F., Jr., I. D. Kuntz, Jr., and G. A. Petsko. 1984. Cavities in proteins: structure of a metmyoglobin-xenon complex solved to 1.9 Å. Biochemistry. 23:2849-2857.
31. Wade, R. C., P. J. Winn, I. Schlichting, and Sudarko. 2004. A survey of active site access channels in cytochromes P450. J. Inorg. Biochem. 98:1175-1182.
32. Lunelli, M., M. L. Di Paolo, M. Biadene, V. Calderone, R. Battistutta, M. Scarpa, A. Rigo, and G. Zanotti. 2005. Crystal structure of amine oxidase from bovine serum. J. Mol. Biol. 346:991-1004.
33. Roeser, D., A. Preusser-Kunze, B. Schmidt, K. Gasow, J. G. Wittmann, T. Dierks, K. von Figura, and M. G. Rudolph. 2006. A general binding mechanism for all human sulfatases by the formylglycine-generating enzyme. Proc. Natl. Acad. Sci. USA. 103:81-86.
34. Bentley, R., and A. Neuberger. 1952. The mechanism of the action of uricase. Biochem. J. 52:694-699.
35. Kahn, K., and P. A. Tipton. 1997. Kinetic mechanism and cofactor content of soybean root nodule urate oxidase. Biochemistry. 36:4731-4738.
36. Kahn, K., and P. A. Tipton. 1998. Spectroscopic characterization of intermediates in the urate oxidase reaction. Biochemistry. 37:11651-11659.
37. Frerichs-Deeken, U., K. Ranguelova, R. Kappl, J. Huttermann, and S. Fetzner. 2004. Dioxygenases without requirement for cofactors and their chemical model reaction: compulsory order ternary complex mechanism of 1H-3-hydroxy-4-oxoquinaldine 2,4-dioxygenase involving general base catalysis by histidine 251 and single-electron oxidation of the substrate dianion. Biochemistry. 43:14485-14499.
38. Sciara, G., S. G. Kendrew, A. E. Miele, N. G. Marsh, L. Federici, F. Malatesta, G. Schimperna, C. Savino, and B. Vallone. 2003. The structure of ActVA-Orf6, a novel type of monooxygenase involved in actinorhodin biosynthesis. EMBO J. 22:205-215.
39. Fetzner, S. 2002. Oxygenases without requirement for cofactors or metal ions. Appl. Microbiol. Biotechnol. 60:243-257.
40. Sarma, A. D., and P. A. Tipton. 2000. Evidence for urate hydroperoxide as an intermediate in the urate oxidase reaction. J. Am. Chem. Soc. 112:11252-11253.
41. Massey, V. 1994. Activation of molecular oxygen by flavins and flavoproteins. J. Biol. Chem. 269:22459-22462.
42. Colloc'h, N., A. Poupon, and J. P. Mornon. 2000. Sequence and structural features of the T-fold, an original tunnelling building unit. Proteins. 39:142-154.
43. Tipton, P. A. 2002. Urate oxidase: single-turnover stopped-flow techniques for detecting two discrete enzyme-bound intermediates. Methods Enzymol. 354:310-319.
44. Imhoff, R. D., N. P. Power, M. J. Borrok, and P. A. Tipton. 2003. General base catalysis in the urate oxidase reaction: evidence for a novel Thr-Lys catalytic diad. Biochemistry. 42:4094-4100.
45. Doll, C., A. F. Bell, N. Power, P. J. Tonge, and P. A. Tipton. 2005. Procatalytic ligand strain. Ionization and perturbation of 8-nitroxanthine at the urate oxidase active site. Biochemistry. 44:11440-11446.
46. Altarsha, M., G. Monard, and B. Castro. 2007. Comparative semiempirical and ab initio study of the structural and chemical properties of uric acid and its anions. Int. J. Quantum Chem. 107:172-181.
47. Li, H., A. D. Robertson, and J. H. Jensen. 2005. Very fast empirical prediction and rationalization of protein pKa values. Proteins. 61:704-721.
48. Tipton, P. A. 2006. Urate to allantoin, specifically (S)-allantoin. Nat. Chem. Biol. 2:124-125.
49. Gould, S. J., G. A. Keller, and S. Subramani. 1988. Identification of peroxisomal targeting signals located at the carboxy terminus of four peroxisomal proteins. J. Cell Biol. 107:897-905.
50. Alvares, K., R. J. Widrow, G. M. Abu-Jawdeh, J. V. Schmidt, A. V. Yeldandi, M. S. Rao, and J. K. Reddy. 1992. Rat urate oxidase produced by recombinant baculovirus expression: formation of peroxisome crystalloid core-like structures. Proc. Natl. Acad. Sci. USA. 89:4908-4912.
51. Melik-Adamyan, W., J. Bravo, X. Carpena, J. Switala, M. J. Maté, I. Fita, and P. C. Loewen. 2001. Substrate flow in catalases deduced from the crystal structures of active site variants of HPII from Escherichia coli. Proteins. 44:270-281.
52. Gouet, P., H. M. Jouve, and O. Dideberg. 1995. Crystal structure of Proteus mirabilis PR catalase with and without bound NADPH. J. Mol. Biol. 249:933-954.
53. Putnam, C. D., A. S. Arvai, Y. Bourne, and J. A. Tainer. 2000. Active and inhibited human catalase structures: ligand and NADPH binding and catalytic mechanism. J. Mol. Biol. 296:295-309.
54. Vogels, G. D., and C. Van der Drift. 1976. Degradation of purines and pyrimidines by microorganisms. Bacteriol. Rev. 40:403-468.
55. Bergmann, F., H. Ungar-Waron, and H. Kwietny-Govrin. 1963. Thiouric acids as substrates and inhibitors of mammalian urate oxidase. Biochem. J. 86:292-298.